论文部分内容阅读
一项来自布法罗·纽约的病例对照研究认为绝经后激素替代疗法(HRT)看来不增加妇女卵巢上皮癌的危险。他们将491名患卵巢上皮癌正在治疗的绝经后妇女(平均年龄55岁)与741名患恶性肿瘤(与雌激
A case-control study from Buffalo, New York, concluded that postmenopausal hormone replacement therapy (HRT) does not appear to increase the risk of ovarian epithelial cancer in women. They compared 491 postmenopausal women (mean age 55 years) who were treated with epithelial ovarian cancer to 741 patients with malignant tumors